<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="9588">Ticlopidine</z:chebi>, an inhibitor of platelet aggregation, is widely used for <z:hpo ids='HP_0004950'>peripheral arterial disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The use of this drug has been associated with neutropenie and other adverse hematologic effects </plain></SENT>
<SENT sid="2" pm="."><plain>Aplastic anemie is a rate complication that carries high mortality </plain></SENT>
<SENT sid="3" pm="."><plain>We describe the case of a 91 years old woman with ticlopedine-induced <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was treated with filgrastim brood spectrum antibiotics and other general supportive care measures </plain></SENT>
<SENT sid="5" pm="."><plain>Despite initial improvement the old woman died 7 weeks after admission for septic shock </plain></SENT>
<SENT sid="6" pm="."><plain>A review of medical literature revealed 24 similar cases </plain></SENT>
<SENT sid="7" pm="."><plain>Filgrastim has been used previous by with variable success </plain></SENT>
</text></document>